WATCH: Kelsey Natsuhara, MD, of @ucsfcancer.bsky.social discusses the rationale for waiting for radiographic progression before switching breast cancer therapy. See our breast cancer page for more insights! #bcsm #oncology www.onclive.com/clinical/bre...

Frank McCormick, PhD, FRS, DSc (Hon), @ucsanfrancisco.bsky.social on his vision for preemptively treating KRAS-driven precancerous lesions, differences between KRAS allele subtypes, and where the field is headed over the next decade. www.cancernetwork.com/view/how-kra...

How KRAS-Targeted Therapy May Advance Toward Cancer Prevention | CancerNetwork

Frank McCormick, PhD, FRS, DSc (Hon), discussed his vision for preemptively treating KRAS-driven precancerous lesions, differences between KRAS allele subtypes, and where the field is headed over the ...

cancernetwork.com

Dr. Roarke Kamber of @ucsfcancer.bsky.social has been named a 2026 Pew-Stewart Scholar. #AACIUpdate: www.aaci-cancer.org/aaci-update-... #Awards #Honors

📅 Aug. 20: Stay up to date on the latest advances in prostate cancer care. Join the free virtual 6th UroToday Journal Club for Patients, moderated by @dr-coops.bsky.social and featuring expert discussion. @ucsfhealth.bsky.social calendar.ucsf.edu/event/6th-ur...

6th UroToday A Journal Club for Prostate Cancer Patients

calendar.ucsf.edu

9th Annual NOVA12SF Saturdat, Oct 24th. A 12 mile community walk to represent the 12% of women diagnosed with breast cancer. Benefits breast health programs and navigation at @zsfgcare.bsky.social and other community groups. Register before August 1st for the early bird special nova-12-sf.org

Nova 12 SF

9th Annual Nova12SF Walk

nova-12-sf.org

October 11th join us for Taste for the Cure: A Taste of Science! 🍎 Learn from @ucsfhealth.bsky.social experts about breast cancer prevention, treatment, survivorship, and wellness through engaging talks, cooking demos, and more. Free to attend, register at: cancer.ucsf.edu/special-even...

It’s a wrap - 16 faculty and students from our department participated at the recent 2026 AAPM COMP Annual meeting in Canada! Our highlights include posters and presentations - read more here! www.linkedin.com/feed/update/... @aapmhq.bsky.social @ucsfcancer.bsky.social

Congratulations Ke Sheng named one of the 39 fellows for @astro-org.bsky.social 2026 - our department's Vice Chair of the Physics Division! The 2026 class and will be recognized at ASTRO’s 68th Annual Meeting in Boston on September 29. See: radonc.ucsf.edu/ke-sheng-phd... @ucsfcancer.bsky.social

Ke Sheng, PhD, named a Fellow of the American Society for Radiation Oncology (ASTRO) for contributions to cancer care - UCSF Department of Radiation Oncology

FASTRO designation recognizes sustained achievement and service to radiation medicine and patient care Ke Sheng, PhD, professor and Vice Chair, Division of Physics, Department of Radiation Oncology at...

radonc.ucsf.edu

“If we can predict how a tumor will respond before starting down a therapeutic path, it would save time, money, and a lot of anxiety” Jennifer Rosenbluth, MD, PhD @ucsanfrancisco.bsky.social on potential of organoids — tiny lab-made replicas of patients' own tumors cancer.ucsf.edu/news/2026/07...

Lung cancer experts discuss the optimal management of CNS disease in EGFR-mutated non–small cell lung cancer. @lauraaldermd.bsky.social @ucsfcancer.bsky.social @dukecancer.bsky.social #lcsm #oncology www.onclive.com/view/imaging...

Imaging Cadence, Radiation Timing, and Osimertinib Dosing Frame CNS Management Decisions in EGFR-Mutated NSCLC | OncLive

Lung cancer experts discuss the optimal management of CNS disease in EGFR-mutated non–small cell lung cancer.

onclive.com

When does a discovery outgrow academia? @ucsanfrancisco.bsky.social's Charly Craik has founded 3 companies (with 3 more in the works) to carry ideas the next step further. His take on how academia and industry each play their part, via @asbmb.bsky.social www.asbmb.org/asbmb-today/...

Building companies for unmet needs

Charles Craik’s entrepreneurial journey shows how curiosity-driven chemistry led to multiple biotech companies, and how tools, collaboration and unmet clinical needs shape when academic discoveries mo...

asbmb.org

Proposing a new approach for aggressive, treatment-resistant pediatric brain tumors. Rongze Olivia Lu & team @neurosurgucsf.bsky.social target protein phosphatase 2A (PP2A) to induce tumor cell senescence and boost immune response in medulloblastoma models: doi.org/10.1172/JCI1... #medulloblastoma

Spotlight: Offering a potential new therapy for aggressive, treatment-resistant pediatric brain tumors: doi.org/10.1172/JCI1... Rongze Olivia Lu & team @neurosurgucsf.bsky.social find targeting protein phosphatase 2A induces tumor cell senescence & boosts immune response in medulloblastoma models.

By administering an immune checkpoint inhibitor before and after surgery, a phase 2 trial for recurrent #glioblastoma at @ucsfhealth.bsky.social may offer a better chance for the immunotherapy to sustain an antitumor immune response: braintumorcenter.ucsf.edu/news/new-imm... @ucsfcancer.bsky.social

Webinar Sept 21st | @ucsfhealth.bsky.social lymphedema program updates and opportunities. Join us for an engaging webinar and Q&A with moderator and speaker John Rose, MD, MPH tiny.ucsf.edu/wif9p9

Kudos Lindsey Draper, MD (w/ mentor Kole Roybal, PhD) at @ucsanfrancisco.bsky.social on receiving a 2026 @damonrunyon.org Cancer Research Foundation Physician-Scientist Training Award. #UCSFProud

Damon Runyon Cancer Research Foundation@damonrunyon.org · 4w ago

Lindsey M. Draper, MD, aims to genetically reprogram immune cells known as tumor-infiltrating lymphocytes to better recognize and eradicate ovarian tumors.

New research led by Rongze "Olivia" Lu, PhD, shows that inhibiting protein phosphatase 2A (PP2A) induces a form of cellular senescence that enhances antitumor immunity in preclinical models of medulloblastoma. braintumorcenter.ucsf.edu/news/turning... @parkerici.bsky.social @ucsfcancer.bsky.social

Journal of Clinical Investigation@jci.org · last mo.

Proposing a new approach for aggressive, treatment-resistant pediatric brain tumors. Rongze Olivia Lu & team @neurosurgucsf.bsky.social target protein phosphatase 2A (PP2A) to induce tumor cell senescence and boost immune response in medulloblastoma models: doi.org/10.1172/JCI1... #medulloblastoma

Diagnosed with terminal brain cancer, Joe spent this Father’s Day with his wife & children, thanks to awake surgery w/ brain mapping. The approach, pioneered by Dr. Mitch Berger, allows surgeons to remove as much tumor as possible while preserving important brain functions. https://ucsfh.org/4vcSx2j

Bay Area terminal cancer patient getting more precious time with family from specialized brain mapping surgery

A Bay Area cancer patient is making more memories and living longer than his initial diagnosis thanks to a groundbreaking treatment for his particularly aggressive form of brain cancer.

ucsfh.org

Researchers from @ucsanfrancisco.bsky.social & @ucberkeleyofficial.bsky.social used AI to identify women at high risk for breast cancer from routine mammograms, cutting diagnostic wait times from weeks to about an hour. radiology.ucsf.edu/news/how-new... via @ucsfimaging.bsky.social

Despite decades of anti-smoking campaigns, cigarettes are “cool” again with some young people. And, yes, they're still terrible for you: “Cigarettes are the most deadly consumer product ever produced,” Dr. Pamela Ling tells @kqedforum.bsky.social. https://ucsfh.org/4wfzKV4

Cigarettes Are Cool Again and Health Advocates are Worried | KQED

We explore the return of smoking's coolness, and how the glamorization of cigarettes complicates the public health conversation around nicotine.

ucsfh.org

Sarcoma Strong 5K/1K Run + Walk Sunday, August 23, 2026 Join @ucsanfrancisco.bsky.social Department of Orthopaedic Surgery in supporting sarcoma patients and advancing sarcoma research. Info/Register: tiny.ucsf.edu/sarcoma Can't join us in person? Participate virtually from August 8-30, 2026.

Cancer risks vary across Asian American communities, but the new ASPIRE Cohort @ucsanfrancisco.bsky.social @ucirvine.bsky.social @ucdavis.bsky.social @cedarssinaicancer.bsky.social and Temple University aims to better understand these disparities www.latimes.com/science/stor... via @latimes.com

One label, many risks: how grouping Asian Americans hides deadly cancer patterns

A nationwide effort that includes many California researchers seeks to find out why some Asian American communities have high rates of certain cancers.

latimes.com

Can We Convince the Body’s “Big Eater” Cells to Devour Tumors? Dr. Roarke Kamber earns funding for research that directs the immune system’s “big eaters,” macrophages, to eat tumor cells www.ucsf.edu/news/2026/06...

Gratitude to Ann Griffin, PhD, ODS-C, of the @ucsanfrancisco.bsky.social Cancer Registry for providing expertise and guidance that have helped shape cancer research, reporting, and quality initiatives. She received the inaugural Enduring Impact Award - well deserved! cancer.ucsf.edu/news/2026/06...

After 11 years as Dean of UCSF School of Medicine and nearly 3 decades at UCSF, Talmadge King Jr., MD, is stepping down at the end of June. A renowned lung specialist. A leader who listened first and spoke last. Read about his legacy of trust and clinical excellence: https://ow.ly/A1Wn50ZbkBS

👏 Congrats to UCSF Urology & @ucsfimaging.bsky.social on their first TULSA-PRO procedure! Drs. Max Bowman & Ryan Kohlbrenner & team used the minimally invasive, MRI-guided therapy to treat a patient with benign prostatic hyperplasia. The patient is doing great & living his life without a catheter! 🎉

"To give them the time that they deserve to be with their families and to live as long as possible with a good quality of life" Dr. Mitch Berger @neurosurgucsf.bsky.social on advanced brain mapping technique helping extend quality of life www.cbsnews.com/sanfrancisco... via @cbsnews.com

Bay Area terminal cancer patient getting more precious time with family from specialized brain mapping surgery

A Bay Area cancer patient is making more memories and living longer than his initial diagnosis thanks to a groundbreaking treatment for his particularly aggressive form of brain cancer.

cbsnews.com

Co-leader Allan Balmain @ucsanfrancisco.bsky.social from the @cancergrand.bsky.social PROMINENT team gives an update on the latest findings published this week in @science.org which identify new opportunities for cancer prevention

Cancer Grand Challenges@cancergrand.bsky.social · 2mo ago

New findings from team PROMINENT in @science.org highlights new ways to think about cancer prevention by modulating clonal dynamics and ensuring that dangerous clones never emerge. Learn more: www.cancergrandchallenges.org/news/competi...

@ucsfimaging.bsky.social & @ucberkeleyofficial.bsky.social's Adam Yala & Dr. Maggie Chung co-founded Voio, a startup building #AI models to help radiologists interpret images faster & predict patient risk for conditions like cancer & heart failure years in advance.

UC Berkeley and UCSF researchers are using AI to revolutionize medical imaging - Berkeley News

Amid a growing shortage of radiologists, a startup named Voio strives to make medical imaging more efficient — and more effective.

bit.ly

Our @ucsanfrancisco.bsky.social Global Cancer Fellowship Program is designed to support the development of future leaders in global oncology through mentorship, training, and international collaboration. Learn more and apply by June 30. globalcancer.ucsf.edu/global-cance... #UCSFGlobalCancer